Citi Analyst Sees 45-60% Upside In Coherus Biosciences
July 27, 2016 at 09:59 AM EDT
Neulasta and Humira biosimilar clarity over next 12 months could lend significant upside to shares of Coherus Biosciences Inc ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.